GLP-1 medications, explained clearly
Plain-language information about Ozempic, Wegovy, Mounjaro, and Zepbound — sourced to FDA labeling, NIH, and peer-reviewed trials. Not medical advice.
Everything you need to know
Four sections covering the full picture — from side effects to drug comparisons to weekly updates.
In-depth articles on side effects, affordability, stopping GLP-1s, insurance coverage, and more. All sourced to clinical evidence.
Browse articles →Comprehensive reference for Ozempic, Wegovy, Mounjaro, and Zepbound — dosing, side effects, approval status, and savings programs.
See all drugs →Head-to-head comparisons across efficacy, cost, side effects, and availability — so you can ask better questions at your next appointment.
Compare drugs →A weekly roundup of FDA decisions, coverage changes, new clinical trial data, and affordability updates. Published every Monday.
Read the digest →Weekly GLP-1 updates, free
FDA decisions, coverage changes, and new research — every Monday morning. No spam. Unsubscribe anytime.
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.